These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


512 related items for PubMed ID: 11299800

  • 1. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S, Tsuchiya E.
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 3. Hypermethylation of the GATA genes in lung cancer.
    Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Dec 01; 10(23):7917-24. PubMed ID: 15585625
    [Abstract] [Full Text] [Related]

  • 4. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S.
    Mol Carcinog; 2003 Nov 15; 38(3):124-9. PubMed ID: 14587097
    [Abstract] [Full Text] [Related]

  • 7. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 8. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC.
    Oncogene; 1998 Nov 26; 17(21):2779-85. PubMed ID: 9840942
    [Abstract] [Full Text] [Related]

  • 9. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.
    J Pathol; 2006 Oct 26; 210(2):192-204. PubMed ID: 16915569
    [Abstract] [Full Text] [Related]

  • 10. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV.
    Oncogene; 2001 Jun 14; 20(27):3528-32. PubMed ID: 11429699
    [Abstract] [Full Text] [Related]

  • 11. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, Kaiser LR, Croce CM.
    Cancer Res; 2003 Jun 15; 63(12):3352-5. PubMed ID: 12810670
    [Abstract] [Full Text] [Related]

  • 14. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.
    Xinarianos G, McRonald FE, Risk JM, Bowers NL, Nikolaidis G, Field JK, Liloglou T.
    Hum Mol Genet; 2006 Jul 01; 15(13):2038-44. PubMed ID: 16698880
    [Abstract] [Full Text] [Related]

  • 15. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 16. SEL1L expression in non-small cell lung cancer.
    Ferrero S, Falleni M, Cattaneo M, Malferrari G, Canton C, Biagiotti L, Maggioni M, Nosotti M, Coggi G, Bosari S, Biunno I.
    Hum Pathol; 2006 May 18; 37(5):505-12. PubMed ID: 16647946
    [Abstract] [Full Text] [Related]

  • 17. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
    Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB, Gabrielson E.
    Oncogene; 1998 Apr 23; 16(16):2159-64. PubMed ID: 9572497
    [Abstract] [Full Text] [Related]

  • 18. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 23; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 23; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 20. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.
    Cancer Res; 2001 Jun 01; 61(11):4556-60. PubMed ID: 11389090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.